Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Early Pharmaceutical Intervention for Cardiovascular Disease Prevention in Stage 1 Hypertension
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Summary
STEP-Pre is to investigate the benefits of using anti-hypertensive drugs in the population with a blood pressure of 130-139/80-89 mmHg and evaluate the health economics. STEP-Pre is a multi-center randomized clinical trial. The cohort will be randomized into the treatment group or control group with a 1:1 ratio. The treatment group will take anti-hypertensive medicine to control blood pressure under 130/80 mmHg. Both groups will take health care education. STEP-Pre will last 4 years.
Key Details
Gender
All
Age Range
35 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
20000
Start Date
2023-01-01
Completion Date
2026-12-31
Last Updated
2022-10-04
Healthy Volunteers
No
Conditions
Interventions
RASI and/or a single pill combination based RASI
The participants in the Treatment group will begin with a single category antihypertensive drug to control their blood pressure, for example, perindopril. If the blood pressure cannot be controlled under 130/80 mmHg, another type of antihypertensive drug will be added.